Product-market fit gets attention. Evidence-market fit gets reimbursement, procurement and scale. Regulatory approval may open the door. Evidence-market fit determines whether health systems will pay, procure, recommend or scale. Many …
-
-
News
NICE, DHSC and NHS England Digital Care Evidence Standards 2026: What HealthTech Companies Must Now Prove
Odelle Intelligence Briefing UK Digital Health, Adult Social Care, Health Economics and Reimbursement Strategy Odelle Technology has reviewed the 2026 direction of travel from NICE, the Department of Health and …
-
News
New Procedure, Old Payment Box: Why the 2026/27 NHS HRG Freeze Matters and How Surgical Innovators Can Work the System
A medtech company arrives in the NHS with what appears to be a breakthrough. The procedure is less invasive. The device is clever. Recovery may be faster. The surgeon can …
-
News
WHY YOU NEED TO THINK before using AI: A Framework for Preserving Critical Thinking in the Age of Artificial Intelligence
Overview Recent research demonstrates a critical insight that should reshape how individuals and organisations approach artificial intelligence: the timing, context, and intentionality behind AI use fundamentally determine whether these tools …
-
Indirect Treatment Comparisons in France: Why HAS Exposes the Limits of Multi-Market Evidence Strategies For over a decade, market access teams have observed a persistent pattern: indirect treatment comparisons (ITCs) …
-
A Structural Shift in Evidence Generation for Medicines and Medical Technologies The implementation of the EU Health Technology Assessment Regulation (HTAR, 2021/2282) marks a fundamental transition in how clinical and …
-
What It Is, How It Works, and What Success Actually Requires Introduction: The Hidden Architecture of French Reimbursement In France, a single institution holds the power to determine whether a …
-
DiappyMed and Sanofi Partnership: Transforming Digital Diabetes Care in France DiappyMed’s €5 million seed funding round and strategic partnership with pharmaceutical giant Sanofi represent a pivotal moment for digital therapeutics …
-
Comprehensive guide to DTx reimbursement in France. Learn how digital therapeutics (DTx) navigate CNEDiMTS evaluation, PECAN requirements, and scientific methodology standards for HAS approval. The Urgency of Securing HAS Approval …
-
The European framework for digital health technology assessment represents a watershed moment for innovation companies seeking reimbursement across fragmented national systems[1][5]. Rather than navigating each country’s unique evaluation pathway from …